Fred Hutch helps lead AI collaboration to transform cancer research and care

Fred Hutchinson Cancer Center in Seattle is helping shape the future of cancer research through its leadership in the Cancer AI Alliance (CAIA), a collaboration using artificial intelligence to accelerate cancer discovery and improve patient care.

Alongside three other National Cancer Institute-designated cancer centers — Dana-Farber Cancer Institute in Boston, Memorial Sloan Kettering Cancer Center in New York and Johns Hopkins in Baltimore — Fred Hutch is contributing expertise and de-identified patient data to a federated AI learning platform. Designed to advance precision cancer care while maintaining patient privacy, the platform enables models to train securely on data stored within each institution, eliminating the need to move sensitive patient data outside the cancer centers.

Insights generated from each institution’s dataset are then aggregated to strengthen the AI models and reveal patterns across larger and more diverse patient populations, including patients with rare cancers. This collaborative infrastructure currently includes clinical data from more than 1 million patients and is expected to expand as additional cancer centers join the initiative.

Over the past year, CAIA has launched eight pilot projects focused on advancing cancer discovery and improving patient outcomes. Through its participation, Fred Hutch is helping drive a more collaborative and data-driven approach to cancer research — accelerating innovation in diagnosis, treatment and precision oncology.

LEARN MORE